Maternal asthma is associated with increased risk of perinatal mortality.

BACKGROUND:Asthma is the most common chronic disease during pregnancy and it may have influence on pregnancy outcome. OBJECTIVES:Our goal was to assess the association between maternal asthma and the perinatal risks as well as possible effects of asthma medication. METHODS:The study was based on a n...

Full description

Bibliographic Details
Main Authors: Mari Kemppainen, Anna-Maria Lahesmaa-Korpinen, Paula Kauppi, Martti Virtanen, Suvi M Virtanen, Riitta Karikoski, Mika Gissler, Turkka Kirjavainen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5959067?pdf=render
id doaj-edbecbd9296b44c8b7cbebc787c2302d
record_format Article
spelling doaj-edbecbd9296b44c8b7cbebc787c2302d2020-11-25T02:23:08ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01135e019759310.1371/journal.pone.0197593Maternal asthma is associated with increased risk of perinatal mortality.Mari KemppainenAnna-Maria Lahesmaa-KorpinenPaula KauppiMartti VirtanenSuvi M VirtanenRiitta KarikoskiMika GisslerTurkka KirjavainenBACKGROUND:Asthma is the most common chronic disease during pregnancy and it may have influence on pregnancy outcome. OBJECTIVES:Our goal was to assess the association between maternal asthma and the perinatal risks as well as possible effects of asthma medication. METHODS:The study was based on a nationwide Finnish register-based cohort between the years 1996 and 2012 in the Drug and Pregnancy Database. The register data comprised 962 405 singleton live and stillbirths, 898 333 (93.3%) pregnancies in mothers with neither confirmed asthma nor use of asthma medication (controls), and 26 674 (2.8%) pregnancies with confirmed maternal asthma. 71% of mothers with asthma used asthma medication. The diagnosis of asthma was based on the mothers' right for subsidised medication which is carefully evaluated by strict criteria including pulmonary function testing. Odds ratio was used in comparison. Premature birth (PB), low birth weight, small for gestational age (SGA), neonatal death were the main outcome measures. RESULTS:Maternal asthma was associated with adjusted odds ratios (aORs) for perinatal mortality 1.24 (95% CI 1.05 to 1.46), preterm birth 1.18 (1.11 to 1.25), low birth weight 1.29 (1.21 to 1.37), fetal growth restriction (SGA) 1.32, (1.24 to 1.40), and asphyxia 1.09 (1.02 to 1.17). Asthma treatment reduced the increased risk of preterm birth aOR 0.85 (95% CI 0.76 to 0.96) but mothers with treated asthma had higher risks of fetal growth restriction (SGA) aOR 1.26 (1.10 to 1.45), and asphyxia aOR 1.37 (1.17 to 1.61) than mothers with untreated asthma. CONCLUSION:Asthma is associated with increased risks of perinatal mortality, preterm birth, low birth weight, fetal growth restriction (SGA), and asphyxia. Asthma treatment reduces the risk of preterm delivery, but it does not seem to reduce other complications such as perinatal mortality.http://europepmc.org/articles/PMC5959067?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Mari Kemppainen
Anna-Maria Lahesmaa-Korpinen
Paula Kauppi
Martti Virtanen
Suvi M Virtanen
Riitta Karikoski
Mika Gissler
Turkka Kirjavainen
spellingShingle Mari Kemppainen
Anna-Maria Lahesmaa-Korpinen
Paula Kauppi
Martti Virtanen
Suvi M Virtanen
Riitta Karikoski
Mika Gissler
Turkka Kirjavainen
Maternal asthma is associated with increased risk of perinatal mortality.
PLoS ONE
author_facet Mari Kemppainen
Anna-Maria Lahesmaa-Korpinen
Paula Kauppi
Martti Virtanen
Suvi M Virtanen
Riitta Karikoski
Mika Gissler
Turkka Kirjavainen
author_sort Mari Kemppainen
title Maternal asthma is associated with increased risk of perinatal mortality.
title_short Maternal asthma is associated with increased risk of perinatal mortality.
title_full Maternal asthma is associated with increased risk of perinatal mortality.
title_fullStr Maternal asthma is associated with increased risk of perinatal mortality.
title_full_unstemmed Maternal asthma is associated with increased risk of perinatal mortality.
title_sort maternal asthma is associated with increased risk of perinatal mortality.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2018-01-01
description BACKGROUND:Asthma is the most common chronic disease during pregnancy and it may have influence on pregnancy outcome. OBJECTIVES:Our goal was to assess the association between maternal asthma and the perinatal risks as well as possible effects of asthma medication. METHODS:The study was based on a nationwide Finnish register-based cohort between the years 1996 and 2012 in the Drug and Pregnancy Database. The register data comprised 962 405 singleton live and stillbirths, 898 333 (93.3%) pregnancies in mothers with neither confirmed asthma nor use of asthma medication (controls), and 26 674 (2.8%) pregnancies with confirmed maternal asthma. 71% of mothers with asthma used asthma medication. The diagnosis of asthma was based on the mothers' right for subsidised medication which is carefully evaluated by strict criteria including pulmonary function testing. Odds ratio was used in comparison. Premature birth (PB), low birth weight, small for gestational age (SGA), neonatal death were the main outcome measures. RESULTS:Maternal asthma was associated with adjusted odds ratios (aORs) for perinatal mortality 1.24 (95% CI 1.05 to 1.46), preterm birth 1.18 (1.11 to 1.25), low birth weight 1.29 (1.21 to 1.37), fetal growth restriction (SGA) 1.32, (1.24 to 1.40), and asphyxia 1.09 (1.02 to 1.17). Asthma treatment reduced the increased risk of preterm birth aOR 0.85 (95% CI 0.76 to 0.96) but mothers with treated asthma had higher risks of fetal growth restriction (SGA) aOR 1.26 (1.10 to 1.45), and asphyxia aOR 1.37 (1.17 to 1.61) than mothers with untreated asthma. CONCLUSION:Asthma is associated with increased risks of perinatal mortality, preterm birth, low birth weight, fetal growth restriction (SGA), and asphyxia. Asthma treatment reduces the risk of preterm delivery, but it does not seem to reduce other complications such as perinatal mortality.
url http://europepmc.org/articles/PMC5959067?pdf=render
work_keys_str_mv AT marikemppainen maternalasthmaisassociatedwithincreasedriskofperinatalmortality
AT annamarialahesmaakorpinen maternalasthmaisassociatedwithincreasedriskofperinatalmortality
AT paulakauppi maternalasthmaisassociatedwithincreasedriskofperinatalmortality
AT marttivirtanen maternalasthmaisassociatedwithincreasedriskofperinatalmortality
AT suvimvirtanen maternalasthmaisassociatedwithincreasedriskofperinatalmortality
AT riittakarikoski maternalasthmaisassociatedwithincreasedriskofperinatalmortality
AT mikagissler maternalasthmaisassociatedwithincreasedriskofperinatalmortality
AT turkkakirjavainen maternalasthmaisassociatedwithincreasedriskofperinatalmortality
_version_ 1724859538092326912